Sugi Predict

Sugi Predict / Compounds / SCHEMBL25049531

SCHEMBL25049531

SCHEMBL25049531

CCOc1cc(C(=O)N(C)Cc2ccc3nc[nH]c3c2)ccc1-c1cccc(F)c1

nearest known ligand 0.59

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
▸ NLRP3 Q96P20 19/20 0.59
▸ CYP1A2 P05177 1/20 0.59
▸ CYP3A4 P08684 1/20 0.59
▸ CYP2D6 P10635 1/20 0.59
▸ CYP2C9 P11712 1/20 0.59
▸ CYP2C19 P33261 1/20 0.59
▸ CTDSP1 Q9GZU7 1/20 0.43
▸ L3MBTL1 Q9Y468 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26816569 0.84 NLRP3 (0.72) NLRP3CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL25048450 0.82 NLRP3 (0.72) NLRP3CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL25049033 0.82 NLRP3 (0.58) NLRP3CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL25049235 0.78 NLRP3 (0.60) NLRP3CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL25920076 0.77 NLRP3 (0.61) NLRP3CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL25048923 0.76 NLRP3 (0.73) NLRP3CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL26816565 0.76 NLRP3 (0.64) NLRP3CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL25049484 0.75 NLRP3 (0.79) NLRP3CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL25048368 0.75 NLRP3 (0.87) NLRP3CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL25046858 0.75 NLRP3 (1.00) NLRP3CYP1A2CYP3A4CYP2D6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240067610-A1 INHIBITORS OF NLRP3 INFLAMMASOME BioAge Labs, Inc. 2024-02-29 — — US disclosed
US-20230365507-A1 INHIBITORS OF NLRP3 INFLAMMASOME BioAge Labs, Inc. 2023-11-16 — — US disclosed
US-20230365507-A1 INHIBITORS OF NLRP3 INFLAMMASOME BioAge Labs, Inc. 2023-11-16 — — US disclosed
US-11708334-B2 Inhibitors of NLRP3 inflammasome BioAge Labs, Inc. (US) 2023-07-25 — — US disclosed
US-11702391-B2 Inhibitors of NLRP3 inflammasome BioAge Labs, Inc. (US) 2023-07-18 — — US disclosed
US-20230051130-A1 INHIBITORS OF NLRP3 INFLAMMASOME BioAge Labs, Inc. 2023-02-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11708334-B2 Inhibitors of NLRP3 inflammasome NLRP3, NLRP1, PYCARD NLRP3 1/4885CYP1A2 3995/4885CYP3A4 4341/4885
US-20240067610-A1 INHIBITORS OF NLRP3 INFLAMMASOME NLRP3, PYCARD, CASP1 NLRP3 1/4885CYP1A2 4372/4885CYP3A4 4449/4885
US-11702391-B2 Inhibitors of NLRP3 inflammasome NLRP3, CASP1, PYCARD NLRP3 1/4885CYP1A2 3857/4885CYP3A4 4378/4885
US-20230051130-A1 INHIBITORS OF NLRP3 INFLAMMASOME NLRP3, PYCARD, CASP1 NLRP3 1/4885CYP1A2 4372/4885CYP3A4 4449/4885
US-20230365507-A1 INHIBITORS OF NLRP3 INFLAMMASOME NLRP3, PYCARD, CASP1 NLRP3 1/4885CYP1A2 4372/4885CYP3A4 4449/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.